Abstract
Background SARS-CoV-2, the virus responsible for the COVID-19 pandemic, can be detected in stool samples and subsequently shed in the sewage system. The field of Wastewater-based epidemiology (WBE) aims to use this valuable source of data for epidemiological surveillance, as it has the potential to identify unreported infections and to anticipate the need for diagnostic tests.
Objectives The objectives of this study were to analyze the absolute concentration of genome copies of SARS-CoV-2 shed in Catalonia’s wastewater during the Omicron peak in January 2022, and to develop a mathematical model capable of using wastewater data to estimate the actual number of infections and the temporal relationship between reported and unreported infections.
Methods We collected twenty-four-hour composite 1-liter samples of wastewater from 16 wastewater treatment plants (WWTPs) in Catalonia on a weekly basis. We incorporated this data into a compartmental epidemiological model that distinguishes between reported and unreported infections and uses a convolution process to estimate the genome copies shed in sewage.
Results The 16 WWTPs showed an average correlation of 0.88 ± 0.08 (ranging from 0.96 to 0.71) and an average delay of 8.7 ± 5.4 days (ranging from 0 to 20 days). Our model estimates that about 53% of the population in our study had been infected during the period under investigation, compared to the 19% of cases that were detected. This under-reporting was especially high between November and December 2021, with values up to 10. Our model also allowed us to estimate the maximum quantity of genome copies shed in a gram of feces by an infected individual, which ranged from 4.15 × 107 gc/g to 1.33 × 108 gc/g.
Discussion Although wastewater data can be affected by uncertainties and may be subject to fluctuations, it can provide useful insights into the current trend of an epidemic. As a complementary tool, WBE can help account for unreported infections and anticipate the need for diagnostic tests, particularly when testing rates are affected by human behavior-related biases.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This work was partially funded by the Catalan Agency for Water (ACA), the Catalan Public Health Agency (ASPCAT) from the Department of Health, and the Health Innovation Program from the General Research Directorate (DGRIS) of the Generalitat de Catalunya. The authors would like to thank the EU and The Spanish State Research Agency for funding project PCI2021-121928, in the frame of the collaborative international consortium SARA financed under the ERA-NET AquaticPollutants Joint Transnational Call (GA n 869178). We kindly acknowledge Promega for the assignment of a Maxwell AS4500 nucleic acids extraction System. This project has received funding from the European Union's Horizon 2020 research and innovation program under the Marie Skłodowska-Curie grant agreement No. 945413 and from the Universitat Rovira i Virgili (URV). Disclaimer: This work reflects only the author's view and the Agency is not responsible for any use that may be made of the information it contains. AA acknowledges the Joint Appointment Program at Pacific Northwest National Laboratory (PNNL). PNNL is a multi-program national laboratory operated for the U.S. Department of Energy (DOE) by Battelle Memorial Institute under Contract No. DE-AC05-76RL01830, the European Union's Horizon Europe Programme under the CREXDATA project, grant agreement no. 101092749, support by Ministerio de Econom\'ia y Competitividad (Grants No.\ PID2021-128005NB-C21), Generalitat de Catalunya (Grant No.\ 2017SGR-896) and Universitat Rovira i Virgili (Grant No.\ 2019PFR-URV-B2-41). A.A.\ also acknowledges ICREA Academia 2023, and the James S.\ McDonnell Foundation (Grant No.\ 220020325).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
All data analyzed are available online
https://analisi.transparenciacatalunya.cat/browse?q=covid&sortBy=relevance
